Cardiovascular benefits: Recent studies suggest that Semaglutide may have cardiovascular benefits, particularly in reducing the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, and cardiovascular death
Who Is at Higher Risk for Problematic Heart Rate Changes Patients with existing arrhythmias such as atrial fibrillation, those with symptomatic tachycardia, uncontrolled coronary disease, or advanced heart failure need closer attention
Prime the Pen (First Use Only): If you're using the pen for the first time, or if it has not been used for a while, you need to prime it to ensure proper dosing
The research-grade alternative is not
Vosoughi K, Roghani R, Camilleri M